Disease Detail

ID DOID:6193
Name epithelioid sarcoma
Definition A connective tissue cancer that is characterized by the presence of epithelioid cells forming nodular patterns and has_material_basis_in mesenchymal tissue. {comment=url:https://en.wikipedia.org/wiki/Epithelioid_sarcoma, comment=url:https://www.mayoclinic.org/diseases-conditions/epithelioid-sarcoma/cdc-20392420}
Source DiseaseOntology.org
Alt Ids
Path disease disease of cellular proliferation cancer organ system cancer musculoskeletal system cancer connective tissue cancer epithelioid sarcoma

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Molecular Profile Therapy Indication/Tumor Type Response Type Profile Response Detail
Unknown unknown Abexinostat epithelioid sarcoma not applicable detail...
Unknown unknown Vorinostat epithelioid sarcoma not applicable detail...
Unknown unknown Entinostat epithelioid sarcoma not applicable detail...
Unknown unknown Dasatinib epithelioid sarcoma not applicable detail...
SMARCB1 negative Tazemetostat epithelioid sarcoma predicted - sensitive detail...
SMARCB1 inact mut N/A epithelioid sarcoma not applicable detail...
SMARCB1 del N/A epithelioid sarcoma not applicable detail...
Clinical Trial Phase Therapies Title Recruitment Status
NCT02584309 Phase II Dexrazoxane Doxorubicin + Olaratumab Doxorubicin With Upfront Dexrazoxane Plus Olaratumab for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma Recruiting
NCT02601937 Phase I Tazemetostat A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma Recruiting
NCT02834013 Phase 0 Ipilimumab + Nivolumab Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Recruiting
NCT03009201 Phase I Doxorubicin + Ribociclib Ribociclib and Doxorubicin Hydrochloride in Treating Patients Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery Recruiting